Denver, Colorado — Advancing kidney disease research takes more than scientific discoveries. It also requires collaboration among the people who design clinical studies, manage their operations, and work directly with participants. The American Society of Nephrology (ASN) Kidney Week brings many of these professionals together each year to share research findings and discuss developments in kidney care.
Taking place October 21–25, 2026, at the Colorado Convention Center in Denver, Colorado, this year's meeting will also provide an opportunity for Biopharma Informatic to connect with professionals across the nephrology and clinical research communities.
Kidney Week provides a forum for sharing research findings, discussing developments in nephrology, and considering the needs of future clinical studies. Turning research priorities into well-planned studies requires input from pharmaceutical sponsors, contract research organizations (CROs), investigators, and research sites. When these partners understand one another's priorities, they can better coordinate their efforts and prepare for the demands of clinical research.
For our team, the event is a chance to share our experience in clinical research operations and contribute to discussions about the practical requirements of study delivery. Through our work with sponsors, CROs, and investigators, we understand the importance of matching research needs with the right site resources and operational support. We hope to bring this perspective to conversations about the future of kidney disease research.
Biopharma Informatic connects pharmaceutical sponsors and CROs with experienced research sites and investigators, supporting clinical studies from startup through execution and closeout.
During Kidney Week, our team plans to discuss practical aspects of trial planning, including protocol requirements, recruitment targets, staffing needs, and the resources required to manage a study effectively. These discussions can help clarify operational expectations and identify considerations that may affect study timelines and site readiness.
Chronic kidney disease (CKD) is among the areas represented in Biopharma Informatic's clinical research portfolio, which includes active chronic kidney disease clinical trials . Research in this field helps investigators evaluate investigational approaches and build evidence that may inform future developments in kidney disease care.
We aim to bring a site-level perspective to these discussions, particularly around the practical considerations that shape clinical study planning and delivery.
Ahead of the event, CEO Shuja Naqvi shared his perspective on the value of connecting with the clinical research community:
“Early communication helps research partners understand what a study requires and how each team can contribute. Kidney Week brings sponsors, CROs, and research sites together, giving us an opportunity to learn about their priorities, discuss practical challenges, and explore where our network can support future research.”
If you're attending ASN Kidney Week 2026 in Denver, we'd be pleased to meet you at Booth 333. Our team looks forward to speaking with pharmaceutical sponsors, CRO representatives, investigators, and nephrology professionals about our research site network, ongoing CKD studies, and the operational considerations involved in running clinical trials.
We value the knowledge and experience each research partner brings to the table, and these discussions give us a chance to exchange perspectives, better understand the needs of the field, and consider how our work can support future clinical research.
Biopharma Informatic
Email: [email protected]
Phone: 281-944-3610
Website: biopharmainfo.net